- Home
- XBIT vs MRCC Comparison
XBIT vs MRCC Comparison
Compare XBIT & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- MRCC
- Stock Information
- Founded
- XBIT 2005
- MRCC 2011
- Country
- XBIT United States
- MRCC United States
- Employees
- XBIT N/A
- MRCC N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- MRCC Investment Managers
- Sector
- XBIT Health Care
- MRCC Finance
- Exchange
- XBIT Nasdaq
- MRCC Nasdaq
- Market Cap
- XBIT 194.5M
- MRCC 174.8M
- IPO Year
- XBIT 2015
- MRCC 2012
- Fundamental
- Price
- XBIT $3.88
- MRCC $8.15
- Analyst Decision
- XBIT
- MRCC Strong Buy
- Analyst Count
- XBIT 0
- MRCC 1
- Target Price
- XBIT N/A
- MRCC $9.00
- AVG Volume (30 Days)
- XBIT 103.6K
- MRCC 71.9K
- Earning Date
- XBIT 11-13-2024
- MRCC 11-12-2024
- Dividend Yield
- XBIT N/A
- MRCC 12.27%
- EPS Growth
- XBIT N/A
- MRCC 298.01
- EPS
- XBIT N/A
- MRCC 0.60
- Revenue
- XBIT N/A
- MRCC $62,007,000.00
- Revenue This Year
- XBIT N/A
- MRCC N/A
- Revenue Next Year
- XBIT N/A
- MRCC N/A
- P/E Ratio
- XBIT N/A
- MRCC $13.58
- Revenue Growth
- XBIT N/A
- MRCC N/A
- 52 Week Low
- XBIT $3.51
- MRCC $6.97
- 52 Week High
- XBIT $9.96
- MRCC $8.80
- Technical
- Relative Strength Index (RSI)
- XBIT 30.26
- MRCC 41.98
- Support Level
- XBIT $3.72
- MRCC $8.09
- Resistance Level
- XBIT $4.67
- MRCC $8.80
- Average True Range (ATR)
- XBIT 0.50
- MRCC 0.21
- MACD
- XBIT -0.05
- MRCC -0.00
- Stochastic Oscillator
- XBIT 11.76
- MRCC 18.75
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.